L1 Capital International Trims HCA Healthcare Position Amid Valuation Concerns
L1 Capital International reduced its position in HCA Healthcare (HCA) during the March 2026 quarter due to valuation considerations. The fund underperformed the MSCI World Net Total Return Index, citing factors like lack of energy exposure and declining share prices in high-quality firms. HCA's stock closed at $488.58 with a 45.84% gain over the past 52 weeks.
Tickers: $HCA
Topics: HCA Healthcare investment strategy portfolio changes valuation analysis